Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)

Clinical trial NCT03648489 · COMPLETED

Trial details

NCT number: NCT03648489
Sponsor: Imperial College London
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Ovarian Neoplasms Ovarian Carcinosarcoma Ovarian Serous Adenocarcinoma Ovarian Endometrioid Adenocarcinoma Ovarian Clear Cell Adenocarcinoma Fallopian Tube Cancer Fallopian Tube Neoplasms Primary Peritoneal Carcinoma Primary Peritoneal Serous Adenocarcinoma

Start date: 2018-09-21
Primary completion: 2023-11-30
Enrollment: 134

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.